Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data

Alice B. Gottlieb; Joseph F. Merola; Rongdean Chen; Eugenia Levi; Kristina Callis Duffin

doi:10.1016/j.jaad.2017.06.162

Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data

Alice B. Gottlieb, Joseph F. Merola, Rongdean Chen, Eugenia Levi, Kristina Callis Duffin

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	English
Pages (from-to)	1178-1180
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	77
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2017.06.162
State	Published - Dec 2017
Externally published	Yes

Access to Document

10.1016/j.jaad.2017.06.162

Cite this

Gottlieb, A. B., Merola, J. F., Chen, R., Levi, E., & Duffin, K. C. (2017). Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. Journal of the American Academy of Dermatology, 77(6), 1178-1180. https://doi.org/10.1016/j.jaad.2017.06.162

Gottlieb, Alice B. ; Merola, Joseph F. ; Chen, Rongdean et al. / Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool : An analysis of apremilast phase 3 ESTEEM data. In: Journal of the American Academy of Dermatology. 2017 ; Vol. 77, No. 6. pp. 1178-1180.

@article{803d48b000a64fa2aef76a36043d4e74,

title = "Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data",

author = "Gottlieb, \{Alice B.\} and Merola, \{Joseph F.\} and Rongdean Chen and Eugenia Levi and Duffin, \{Kristina Callis\}",

note = "Funding Information: The authors received editorial support in preparation of the Research Letter from Karen Dougherty, PhD, and Kristin E. Larsen, PhD, of Peloton Advantage, LLC, funded by Celgene Corporation. The authors, however, directed and are fully responsible for all content and editorial decisions for this Research Letter.",

year = "2017",

month = dec,

doi = "10.1016/j.jaad.2017.06.162",

language = "English",

volume = "77",

pages = "1178--1180",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "6",

}

Gottlieb, AB, Merola, JF, Chen, R, Levi, E & Duffin, KC 2017, 'Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data', Journal of the American Academy of Dermatology, vol. 77, no. 6, pp. 1178-1180. https://doi.org/10.1016/j.jaad.2017.06.162

Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. / Gottlieb, Alice B.; Merola, Joseph F.; Chen, Rongdean et al.
In: Journal of the American Academy of Dermatology, Vol. 77, No. 6, 12.2017, p. 1178-1180.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool

T2 - An analysis of apremilast phase 3 ESTEEM data

AU - Gottlieb, Alice B.

AU - Merola, Joseph F.

AU - Chen, Rongdean

AU - Levi, Eugenia

AU - Duffin, Kristina Callis

N1 - Funding Information: The authors received editorial support in preparation of the Research Letter from Karen Dougherty, PhD, and Kristin E. Larsen, PhD, of Peloton Advantage, LLC, funded by Celgene Corporation. The authors, however, directed and are fully responsible for all content and editorial decisions for this Research Letter.

PY - 2017/12

Y1 - 2017/12

UR - https://www.scopus.com/pages/publications/85033671153

U2 - 10.1016/j.jaad.2017.06.162

DO - 10.1016/j.jaad.2017.06.162

M3 - Article

C2 - 29132853

AN - SCOPUS:85033671153

SN - 0190-9622

VL - 77

SP - 1178

EP - 1180

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Gottlieb AB, Merola JF, Chen R, Levi E, Duffin KC. Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. Journal of the American Academy of Dermatology. 2017 Dec;77(6):1178-1180. doi: 10.1016/j.jaad.2017.06.162